CN105861735A - Rap1b在冠心病诊断中的应用 - Google Patents
Rap1b在冠心病诊断中的应用 Download PDFInfo
- Publication number
- CN105861735A CN105861735A CN201610440177.2A CN201610440177A CN105861735A CN 105861735 A CN105861735 A CN 105861735A CN 201610440177 A CN201610440177 A CN 201610440177A CN 105861735 A CN105861735 A CN 105861735A
- Authority
- CN
- China
- Prior art keywords
- rap1b
- heart disease
- gene
- coronary heart
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
试剂 | 体积 |
正向引物 | 1μl |
反向引物 | 1μl |
SYBR Green聚合酶链式反应体系 | 12.5μl |
模板 | 2μl |
去离子水 | 补足25μl |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610440177.2A CN105861735A (zh) | 2016-06-17 | 2016-06-17 | Rap1b在冠心病诊断中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610440177.2A CN105861735A (zh) | 2016-06-17 | 2016-06-17 | Rap1b在冠心病诊断中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105861735A true CN105861735A (zh) | 2016-08-17 |
Family
ID=56650864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610440177.2A Pending CN105861735A (zh) | 2016-06-17 | 2016-06-17 | Rap1b在冠心病诊断中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105861735A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110241208A (zh) * | 2019-08-02 | 2019-09-17 | 辽宁中医药大学 | Trem2作为早期诊断冠心病的分子标志物的应用 |
CN114650847A (zh) * | 2019-09-25 | 2022-06-21 | 犹他大学研究基金会 | 用于表达来自vmd2启动子的组成型活性rap1a的方法和组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105567861A (zh) * | 2016-03-16 | 2016-05-11 | 宫蕊 | Ifi27作为冠心病诊断标志物的用途 |
CN105567862A (zh) * | 2016-03-16 | 2016-05-11 | 宫蕊 | Cdk18在制备诊断冠心病产品中的用途 |
-
2016
- 2016-06-17 CN CN201610440177.2A patent/CN105861735A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105567861A (zh) * | 2016-03-16 | 2016-05-11 | 宫蕊 | Ifi27作为冠心病诊断标志物的用途 |
CN105567862A (zh) * | 2016-03-16 | 2016-05-11 | 宫蕊 | Cdk18在制备诊断冠心病产品中的用途 |
Non-Patent Citations (1)
Title |
---|
JUN MA等: "Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease", 《GENE PROFILING IDENTIFIES SECRETED PROTEIN TRANSCRIPTS FROM PERIPHERAL BLOOD CELLS IN CORONARY ARTERY DISEASE》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110241208A (zh) * | 2019-08-02 | 2019-09-17 | 辽宁中医药大学 | Trem2作为早期诊断冠心病的分子标志物的应用 |
CN114650847A (zh) * | 2019-09-25 | 2022-06-21 | 犹他大学研究基金会 | 用于表达来自vmd2启动子的组成型活性rap1a的方法和组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105143467B (zh) | 用于预测间质性肺炎的风险的方法 | |
CN101970692B (zh) | 使用肺癌特异性甲基化标记基因检测肺癌的方法 | |
JP6968894B2 (ja) | メチル化dnaの多重検出方法 | |
JP7306723B2 (ja) | 遺伝子のcpgメチル化変化を用いた肝癌の予後または危険度を評価する方法 | |
Elmore et al. | Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12. 3 by genome wide association | |
CN105543408B (zh) | 冠心病早期诊断标志物 | |
KR20120065959A (ko) | 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법 | |
AU2021290268A1 (en) | Immunorepertoire normality assessment method and its use | |
Crocitto et al. | Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results | |
KR101992786B1 (ko) | Cyp2e1 유전자의 메틸화 수준을 이용한 비만의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 | |
CN108342477A (zh) | 基于多个基因诊断肺癌患者的检测试剂盒 | |
CN105567861B (zh) | Ifi27作为冠心病诊断标志物的用途 | |
JP2024507981A (ja) | うつ病の診断及び抗うつ剤治療に対する応答の予測のための環状rna | |
Kiaei et al. | Detection of t (8; 14) c-myc/IgH gene rearrangement by long-distance polymerase chain reaction in patients with diffuse large B-cell lymphoma | |
CN108884492A (zh) | 借助多中心mirna谱的阿尔茨海默病中的特定标记 | |
KR101992789B1 (ko) | Bzrap1-as1 유전자의 메틸화 수준을 이용한 비만의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 | |
CN105861735A (zh) | Rap1b在冠心病诊断中的应用 | |
EP3368684B1 (en) | Biomarker for breast cancer | |
KR101992787B1 (ko) | Bzrap1-as1 유전자의 메틸화 수준을 이용한 고혈압의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 | |
JPWO2018212247A1 (ja) | Egfr変異非小細胞肺がんにおけるegfrチロシンキナーゼ阻害剤の治療奏功性の予測方法 | |
KR102543907B1 (ko) | 치주질환 위험도 평가용 유전자 마커 | |
KR102085663B1 (ko) | Wrb 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 | |
KR102085669B1 (ko) | Cyp26c1 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 | |
KR101601943B1 (ko) | 난소암 환자의 항암제 치료 반응성 예측을 위한 마커 uchl1 | |
KR102085667B1 (ko) | Gpr160 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant after: BEIJING MEDINTELL BIOMED Co.,Ltd. Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Applicant before: BEIJING MEDINTELL BIOMED Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191212 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Applicant after: Qingdao Yangshen biomedical Co.,Ltd. Address before: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant before: BEIJING MEDINTELL BIOMED Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160817 |
|
RJ01 | Rejection of invention patent application after publication |